207 related articles for article (PubMed ID: 19143565)
21. Specific inhibition of AGC protein kinases by antibodies against C-terminal epitopes.
Traincard F; Giacomoni V; Veron M
FEBS Lett; 2004 Aug; 572(1-3):276-80. PubMed ID: 15304362
[TBL] [Abstract][Full Text] [Related]
22. A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.
Davies TG; Verdonk ML; Graham B; Saalau-Bethell S; Hamlett CC; McHardy T; Collins I; Garrett MD; Workman P; Woodhead SJ; Jhoti H; Barford D
J Mol Biol; 2007 Mar; 367(3):882-94. PubMed ID: 17275837
[TBL] [Abstract][Full Text] [Related]
23. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
[TBL] [Abstract][Full Text] [Related]
24. 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.
Bandarage U; Hare B; Parsons J; Pham L; Marhefka C; Bemis G; Tang Q; Moody CS; Rodems S; Shah S; Adams C; Bravo J; Charonnet E; Savic V; Come JH; Green J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5191-4. PubMed ID: 19632115
[TBL] [Abstract][Full Text] [Related]
25. Rational design of inhibitors that bind to inactive kinase conformations.
Liu Y; Gray NS
Nat Chem Biol; 2006 Jul; 2(7):358-64. PubMed ID: 16783341
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule FRET probes for protein kinase activity monitoring in living cells.
Vaasa A; Lust M; Terrin A; Uri A; Zaccolo M
Biochem Biophys Res Commun; 2010 Jul; 397(4):750-5. PubMed ID: 20541535
[TBL] [Abstract][Full Text] [Related]
27. Dynamic binding of PKA regulatory subunit RI alpha.
Gullingsrud J; Kim C; Taylor SS; McCammon JA
Structure; 2006 Jan; 14(1):141-9. PubMed ID: 16407073
[TBL] [Abstract][Full Text] [Related]
28. Discovery of cyclin-dependent kinase inhibitor, CR229, using structurebased drug screening.
Kim MK; Min J; Choi BY; Lim H; Cho YH; Lee CH
J Microbiol Biotechnol; 2007 Oct; 17(10):1712-6. PubMed ID: 18156791
[TBL] [Abstract][Full Text] [Related]
29. Solution scattering reveals large differences in the global structures of type II protein kinase A isoforms.
Vigil D; Blumenthal DK; Taylor SS; Trewhella J
J Mol Biol; 2006 Mar; 357(3):880-9. PubMed ID: 16460759
[TBL] [Abstract][Full Text] [Related]
30. Bisubstrate inhibitors of protein kinases: from principle to practical applications.
Lavogina D; Enkvist E; Uri A
ChemMedChem; 2010 Jan; 5(1):23-34. PubMed ID: 19774589
[TBL] [Abstract][Full Text] [Related]
31. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
32. Diversity of bisubstrate binding modes of adenosine analogue-oligoarginine conjugates in protein kinase a and implications for protein substrate interactions.
Pflug A; Rogozina J; Lavogina D; Enkvist E; Uri A; Engh RA; Bossemeyer D
J Mol Biol; 2010 Oct; 403(1):66-77. PubMed ID: 20732331
[TBL] [Abstract][Full Text] [Related]
33. PKA from Mucor circinelloides: model to study the role of linker I in the interaction between R and C subunits.
Ocampo J; Moreno S; Rossi S
Biochem Biophys Res Commun; 2007 Oct; 362(3):721-6. PubMed ID: 17761146
[TBL] [Abstract][Full Text] [Related]
34. A subnanomolar fluorescent probe for protein kinase CK2 interaction studies.
Enkvist E; Viht K; Bischoff N; Vahter J; Saaver S; Raidaru G; Issinger OG; Niefind K; Uri A
Org Biomol Chem; 2012 Nov; 10(43):8645-53. PubMed ID: 23032938
[TBL] [Abstract][Full Text] [Related]
35. Functional characterisation of the regulatory subunit of cyclic AMP-dependent protein kinase A homologue of Giardia lamblia: Differential expression of the regulatory and catalytic subunits during encystation.
Gibson C; Schanen B; Chakrabarti D; Chakrabarti R
Int J Parasitol; 2006 Jun; 36(7):791-9. PubMed ID: 16472811
[TBL] [Abstract][Full Text] [Related]
36. Physical nature of intermolecular interactions within cAMP-dependent protein kinase active site: differential transition state stabilization in phosphoryl transfer reaction.
Szarek P; Dyguda-Kazimierowicz E; Tachibana A; Sokalski WA
J Phys Chem B; 2008 Sep; 112(37):11819-26. PubMed ID: 18720966
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase A targeting and activation as seen by small-angle solution scattering.
Trewhella J
Eur J Cell Biol; 2006 Jul; 85(7):655-62. PubMed ID: 16460833
[TBL] [Abstract][Full Text] [Related]
38. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for the activity of the RSK-specific inhibitor, SL0101.
Smith JA; Maloney DJ; Hecht SM; Lannigan DA
Bioorg Med Chem; 2007 Jul; 15(14):5018-34. PubMed ID: 17512736
[TBL] [Abstract][Full Text] [Related]
40. Kinetic analysis of inhibition of cAMP-dependent protein kinase catalytic subunit by the peptide-nucleoside conjugate AdcAhxArg6.
Kuznetsov A; Uri A; Raidaru G; Järv J
Bioorg Chem; 2004 Dec; 32(6):527-35. PubMed ID: 15530993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
